Neuroscience
Amyotrophic Lateral Sclerosis
100%
Polyneuropathy
21%
Placebo
17%
Human Immunoglobulin
15%
Neurodegenerative Disorder
13%
Intravenous Immunoglobulin
11%
Rasagiline
10%
Myasthenia gravis
10%
Randomized Controlled Trial
10%
Oxidative Stress
8%
Neuropathy
8%
T Cell
7%
Diabetes Mellitus
5%
Neuroscience
5%
Lipid Peroxidation
5%
Apolipoprotein E
5%
Lithium Carbonate
5%
Somatomedin
5%
TAR DNA Binding Protein
5%
Immune-Mediated Neuropathy
5%
Myotonic Dystrophy
5%
Hematopoietic Cell
5%
Eculizumab
5%
Body Mass Index
5%
Methotrexate
5%
Phosphatase
5%
Dysarthria
5%
Charcot-Marie-Tooth Disease
5%
Nervous System Disorder
5%
Primary Lateral Sclerosis
5%
Keyphrases
Amyotrophic Lateral Sclerosis
15%
Disease Progression
13%
Hizentra
10%
Treg
10%
Lymphocyte Infusion
10%
Treg Lymphocytes
10%
Myotonic Dystrophy
10%
Placebo
9%
Subcutaneous Immunoglobulin
6%
Placebo-controlled
6%
ALSFRS-R
5%
Varicella
5%
Common Complications
5%
Vasculitis
5%
Dose Escalation
5%
Gene Discovery
5%
Prolonged Survival
5%
Target Engagement
5%
Adaptive Platform Trial
5%
Lithium Carbonate
5%
Efficient Trial Design
5%
Insulin-like Growth Factor Type I
5%
Chronic Inflammatory Polyneuropathy
5%
Fluid Uptake
5%
Privigen
5%
Kinesin Superfamily
5%
ALS Gene
5%
Care Recommendations
5%
Risk Genes
5%
Autoimmune Neuropathy
5%
Hypercaloric Diet
5%
Chronic Inflammatory Demyelinating Polyneuropathy
5%
CMT4J
5%
Risk Pathway
5%
Severe Neuropathy
5%
PI(3,5)P2
5%
Orthostatic Hypotension
5%
Placebo Effect
5%
Protein Kinase
5%
First-in-man Study
5%
Neurogenic Orthostatic Hypotension
5%
R47H
5%
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
5%
Future Forecasting
5%
Polyneuropathy
5%
POLG mutation
5%
Sensory Ataxic Neuropathy
5%
Familial ALS
5%
First-in-human Study
5%
HFE Gene
5%
Medicine and Dentistry
Amyotrophic Lateral Sclerosis
42%
Infusion
12%
Regulatory T Lymphocyte
11%
Diseases
9%
Disease Exacerbation
7%
Gene Therapy
6%
Chickenpox
5%
Neurology
5%
Genome Wide Association Study
5%
Baliforsen
5%
Vasculitis
5%
Orthostatic Hypotension
5%
Neurologic Disease
5%
Somatomedin
5%
Chronic Inflammatory Demyelinating Polyneuropathy
5%
Kinesin
5%
Hematopoietic Stem Cell Transplantation
5%
Human Study
5%
Polyneuropathy
5%
Human Immunoglobulin
5%
Myotonic Dystrophy
5%
TAR DNA Binding Protein
5%
Pancreas Transplantation
5%
Immunoglobulin
5%
Primary Lateral Sclerosis
5%
